统计剂单疗法和统计剂加以西西米布组合在现实环境中的比较有效性和安全性
Marat V Ezhov1, Igor V Sergienko1, Sergey M Kryzhanovskiy2
1Federal State Budgetary Institution, National Medical Research Center of Cardiology Named after Academician E.I. Chazov of the Ministry of Health of the Russian Federation, 121552 Moscow, Russia.
Diseases (Basel, Switzerland)
|November 21, 2023
概括
在现实世界高胆固醇血症治疗中,他类药物/ezetimibe组合治疗在降低LDL胆固醇方面比单独使用他类药物更有效. 这种组合显著增加了实现目标LDL-C目标的可能性.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 高胆固醇血症的管理对于预防心血管疾病至关重要.
- 类药物是第一线治疗,但许多患者无法达到目标脂质水平.
- 埃泽提米布提供了替代或补充疗法,以提高降脂效果.
研究的目的:
- 为了比较ezetimibe/他类药物联合治疗与他类药物单一治疗的有效性.
- 评估在现实环境中达到目标低密度脂蛋白胆固醇 (LDL-C) 水平的程度.
- 评估埃泽胺基添加对LDL-C目标实现的影响.
主要方法:
- 在俄罗斯进行的回顾性多中心观察性研究.
- 包括1000名接受他类药物或他类药物/ezetimibe治疗3个月以上的患者.
- 主要终点:达到目标LDL-C水平的频率.
主要成果:
- 组合疗法显示LDL-C的降低更大 (-38.2%对 -27.5%,p < 0.001).
- 目标LDL-C水平在组合治疗中更频繁地实现 (28.8%与22.4%,p = 0.049).
- 静止素单疗组的基线脂质和高血压患病率较高.
结论:
- 在现实世界的高胆固醇血症管理中,他/ezetimibe联合治疗比他单一疗法更有效.
- 将埃泽蒂米布添加到他类药物治疗中,将实现LDL-C目标的概率提高29%.
- 组合疗法是优化脂质管理的一个有价值的策略.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
672
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
672
01:20Antiepileptic Drugs: Potassium Channel Activators
188
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
188
01:22Dose-Response Relationship: Potency and Efficacy
4.5K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.5K
01:27Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
01:12Hazard Ratio
134
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
134
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
130
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
130